Cumberland Pharmaceuticals (CPIX) Long-Term Investments (2025 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Long-Term Investments of $3.8 million for Q1 2026, down 3.66% sequentially from $4.0 million in Q4 2025.
Cumberland Pharmaceuticals (CPIX) Long-Term Investments (2025 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Long-Term Investments for 2 years, with the latest figure at $3.8 million in Q1 2026.
- Quarterly Long-Term Investments changed N/A year-over-year to $3.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 million (changed N/A YoY) and the FY2025 annual result came in at $4.0 million, changed N/A from the prior year.
- Long-Term Investments fell to $3.8 million in Q1 2026 per CPIX's latest filing, from $4.0 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $4.0 million in Q4 2025 and troughed at $3.8 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 60.00 Mn |
| 10 | Cumberland Pharmaceuticals | 116.71 Mn | 112.84 Mn | - | 40,879.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.84 Mn |
| Dec 31, 2025 | 3.99 Mn |